本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Pacific Biosciences of Californi

1.17
-0.0300-2.50%
盤後1.180.0050+0.43%19:56 EDT
成交量:409.05萬
成交額:486.75萬
市值:3.48億
市盈率:-1.04
高:1.22
開:1.20
低:1.16
收:1.20
資料載入中...
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/11

重要事件披露

Form 8-K - Current report